We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID-19: Hyperinflammatory Syndrome and Hemoadsorption with CytoSorb.
- Authors
Masmouei, Behnam; Harorani, Mehdi; Bazrafshan, Mohammad-Rafi; Karimi, Zahra
- Abstract
Based on the above-mentioned points, it is hypothesized that this treatment modality is effective in treating critically ill patients with COVID-19 with ARDS and hyperinflammatory syndrome by removing inflammatory factors from the plasma. The first cause of death in these patients was acute respiratory failure syndrome (ARDS) [[5]], and the second reason has been found to be hyperinflammatory syndrome [[6]]. Following the emergence of a novel coronavirus from Wuhan, China, the world faced a major problem, so many countries were shocked by the outbreak of this virus.
- Subjects
COVID-19; MIDDLE East respiratory syndrome; SARS-CoV-2; COVID-19 pandemic; SYNDROMES
- Publication
Blood Purification, 2021, Vol 50, Issue 6, p976
- ISSN
0253-5068
- Publication type
Letter
- DOI
10.1159/000512199